The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility

Nutrients

Volumn 8, Issue 2, 2016, Pages

  Ozdal, Tugba ^a   Sela, David A ^b   Xiao, Jianbo ^c   Boyacioglu, Dilek ^d   Chen, Fang ^e   Capanoglu, Esra ^d  

^a OKAN UNIVERSITY   (Turkey)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c University of Macau   (Macao)

^d ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

^e CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bioavailability; Flavonoids; Gut microbiota; Health; Interactions; Microbial metabolism; Phenolics; Polyphenols

Indexed keywords

ANTHOCYANIN; DAIDZEIN; DELPHINIDIN; ELLAGITANNIN; EPICATECHIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID GLYCOSIDE; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN; MALVIDIN CHLORIDE GLUCOSIDE; NARINGENIN; PELARGONIDIN; PHENOLIC ACID; POLYPHENOL; PROANTHOCYANIDIN; QUERCETIN; RESVERATROL; STILBENE; UNCLASSIFIED DRUG;

BACTEROIDES; BIFIDOBACTERIUM ADOLESCENTIS; BIOAVAILABILITY; BIOTRANSFORMATION; CLOSTRIDIUM; DEGRADATION KINETICS; ERYSIPELOTRICHACEAE; EUBACTERIUM; FOOD INTAKE; HOST PATHOGEN INTERACTION; HUMAN; HYDROXYLATION; INTESTINE FLORA; MASS SPECTROMETRY; METABOLIC REGULATION; METABOLITE; MICROBIAL GROWTH; MICROBIAL METABOLISM; REVIEW; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; DRUG EFFECTS; METABOLISM;

BIOLOGICAL AVAILABILITY; GASTROINTESTINAL MICROBIOME; HUMANS; POLYPHENOLS;

EID: 84958047393     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8020078     Document Type: Review

References (181)

1. Vinson, J.A.; Su, X.; Zubik, L.; Bose, P. Phenol antioxidant quantity and quality in foods: Fruits. J. Agric. Food Chem. 2001, 49, 5315–5321. [CrossRef][PubMed]
2. Scalbert, A.; Manach, C.; Morand, C.; Remesy, C.; Jimenez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287–306. [CrossRef][PubMed]
3. Khurana, S.; Venkataraman, K.; Hollingsworth, A.; Piche, M.; Tai, T.C. Polyphenols: Benefits to the cardiovascular system in health and in ageing. Nutrients 2013, 5, 3779–3827. [CrossRef][PubMed]
4. Meydani, M.; Hasan, S.T. Dietary polyphenols and obesity. Nutrients 2010, 2, 737–751. [CrossRef][PubMed]
5. Li, A.-N.; Li, S.; Zhang, Y.-J.; Xu, X.-R.; Chen, Y.-M.; Li, H.-B. Resources and biological activities of natural polyphenols. Nutrients 2014, 6, 6020–6047. [CrossRef][PubMed]
6. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230–242.
7. Parada, J.; Aguilera, J.M. Food microstructure affects the bioavailability of several nutrients. J. Food Sci. 2007, 72, 21–32. [CrossRef][PubMed]
8. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073–2085.
9. Lee, H.C.; Jenner, A.M.; Low, C.S.; Lee, Y.K. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157, 876–884. [CrossRef][PubMed]
10. Van Duynhoven, J.; Vaughan, E.E.; Jacobs, D.M.; Kemperman, R.A.; van Velzen, E.J.J.; Gross, G.; Roger, L.C.; Possemiers, S.; Smilde, A.K.; Doré, J. et al. Metabolic fate of polyphenols in the human superorganism. Proc. Natl. Acad. Sci. USA 2011, 108, 4531–4538. [CrossRef][PubMed]
11. Mosele, J.; Macià, A.; Motilva, M.-J. Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: A review. Molecules 2015, 20, 17429–17468. [CrossRef][PubMed]
12. Moco, S.; Martin, F.P.J.; Rezzi, S. Metabolomics view on gut microbiome modulation by polyphenol-rich foods. J. Proteome Res. 2012, 11, 4781–4790. [CrossRef][PubMed]
13. Tuohy, K.M.; Conterno, L.; Gasperotti, M.; Viola, R. Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J. Agric. Food Chem. 2012, 60, 8776–8782. [CrossRef][PubMed]
14. Valdés, L.; Cuervo, A.; Salazar, N.; Ruas-Madiedo, P.; Gueimonde, M.; González, S. The relationship between phenolic compounds from diet and microbiota: Impact on human health. Food Funct. 2015, 6, 2424–2439. [CrossRef][PubMed]
15. Duda-Chodak, A.; Tarko, T.; Satora, P.; Sroka, P. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: A review. Eur. J. Nutr. 2015, 54, 325–341. [CrossRef][PubMed]
16. Dueñas, M.; Muñoz-González, I.; Cueva, C.; Jiménez-Girón, A.; Sánchez-Patán, F.; Santos-Buelga, C.; Moreno-Arribas, M.V.; Bartolome, B. A survey of modulation of gut microbiota by dietary polyphenols. Biomed. Res. Int. 2015, 2015, 1–15.
17. He, X.; Marco, M.L.; Slupsky, C.M. Emerging aspects of food and nutrition on gut microbiota. J. Agric. Food Chem. 2013, 61, 9559–9574. [CrossRef][PubMed]
18. Possemiers, S.; Bolca, S.; Verstraete, W.; Heyerick, A. The intestinal microbiome: A separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 2011, 82, 53–66. [CrossRef][PubMed]
19. Alminger, M.; Aura, A.M.; Bohn, T.; Dufour, C.; El, S.N.; Gomes, A.; Karakaya, S.; Martines-Cuesta, M.C.; McDougall, G.J.; Requena, T. et al. In vitro models for studying secondary plant metabolite digestion and bioaccessibility. Compr. Rev. Food Sci. Food Saf. 2014, 13, 413–436. [CrossRef]
20. Puupponen-Pimiä, R.; Aura, A.M.; Oksman Caldentey, K.M.; Myllärinen, P.; Saarela, M.; Mattila-Sandholm, T.; Poutenen, K. Development of functional ingredients for gut health. Trends Food Sci. Technol. 2002, 13, 3–11. [CrossRef]
21. Chen, D.; Wan, S.B.; Yang, H.; Yuan, J.; Chan, T.H.; Dou, Q.P. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv. Clin. Chem. 2011, 53, 155–177. [PubMed]
22. Weng, C.J.; Yen, G.C. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol and their derivatives. Cancer Treat. Rev. 2012, 38, 76–87. [CrossRef][PubMed]
23. Kuriyama, S.; Shimazu, T.; Ohmori, K.; Kikuchi, N.; Nakaya, N.; Nishino, Y.; Tsubono, Y.; Tsuji, I. Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan. J. Am. Med. Assoc. 2006, 296, 1255–1265. [CrossRef][PubMed]
24. Mursu, J.; Voutilainen, S.; Nurmi, T.; Tuomainen, T.P.; Kurt, S.; Salonen, J.T. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-ages Finnish men. J. Nutr. 2008, 100, 890–895. [CrossRef][PubMed]
25. Jeong, W.Y.; Jin, J.S.; Cho, Y.A.; Lee, J.H.; Park, S.; Jeong, S.W.; Kim, Y.-H.; Lim, C.-S.; El-Aty, A.M.; Kim, G.-S. et al. Determination of polyphenols in three Capsicum annuum L. (bell pepper) varieties using high-performance liquid chromatography–tandem mass spectrometry: Their contribution to overall antioxidant and anticancer activity. J. Sep. Sci. 2011, 34, 2967–2974. [CrossRef][PubMed]
26. Ogunleye, A.A.; Xue, F.; Michels, K.B. Green tea consumption and breast cancer risk or recurrence: A meta-analysis. Breast Cancer Res. Treat. 2009, 119, 477–484. [CrossRef][PubMed]
27. Liu, L.; Zubik, L.; Collins, F.W.; Marko, M.; Meydani, M. The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 2004, 175, 39–49. [CrossRef][PubMed]
28. Mulvihill, E.E.; Huff, M.W. Antiatherogenic properties of flavonoids: Implications for cardiovascular health. Can. J. Cardiol. 2010, 26, 17–21. [CrossRef]
29. Zakaria, Z.A.; Hisam, E.E.A.; Rofiee, M.S.; Norhafizah, M.; Somchit, M.N.; Teh, L.K.; Salleh, M.Z. In vivo antiulcer activity of the aqueous extract of Bauhinia purpurea leaf. J. Ethnopharmacol. 2011, 137, 1047–1054. [CrossRef][PubMed]
30. Han, N.; Gu, Y.; Ye, C.; Cao, Y.; Liu, Z.; Yin, J. Antithrombotic activity of fractions and components obtained from raspberry leaves (Rubus chingii). Food Chem. 2012, 132, 181–185. [CrossRef][PubMed]
31. Tao, W.W.; Duan, J.A.; Yang, N.Y.; Tang, Y.P.; Liu, M.Z.; Qian, Y.F. Antithrombotic phenolic compounds from Glycyrrhiza uralensis. Fitoterapia 2012, 83, 422–425. [CrossRef][PubMed]
32. Beara, I.N.; Lesjak, M.M.; Orcic, D.Z.; Simin, N.D.; Cetoyevic-Simin, D.D.; Bozin, B.; Mimica Dukic, N.M. Comparative analysis of phenolic profile, antioxidant, anti-inflammatory and cytotoxic activity of two closely-related plantain species: Plantago altissima L. and Plantago lanceolata L. LWT Food Sci. Technol. 2012, 47, 64–70. [CrossRef]
33. Zimmer, A.R.; Leonardi, B.; Miron, D.; Schapoval, E.; Oliveira, J.R.; Gosmann, G. Antioxidant and anti-inflammatory properties of Capsicum baccatum: From traditional use to scientific approach. J. Ethnopharmacol. 2012, 139, 228–233. [CrossRef][PubMed]
34. Chung, S.Y.; Champagne, E.T. Reducing the allergenic capacity of peanut extracts and liquid peanut butter by phenolic compounds. Food Chem. 2009, 115, 1345–1349. [CrossRef]
35. Schmitz-Eiberger, M.A.; Blanke, M.M. Bioactive components in forced sweet cherry fruit (Prunus avium L.) antioxidative capacity and allergenic potential as dependent on cultivation under cover. LWT Food Sci. Technol. 2012, 46, 388–392. [CrossRef]
36. Bijak, M.; Bobrowski, M.; Borowiecka, M.; Podşedek, A.; Golánski, J.; Nowak, P. Anticoagulant effect of polyphenols-rich extracts from black chokeberry and grape seeds. Fitoterapia 2011, 82, 811–817. [CrossRef][PubMed]
37. Schütz, K.; Saß, M.; With, A.; Graubaum, H.J.; Grünwald, J. Immunemodulating efficacy of a polyphenol-rich beverage on symptoms associated with the common cold: A double-blind, randomised, placebo-controlled, multi-centric clinical study. Br. J. Nutr. 2010, 104, 1156–1164. [CrossRef][PubMed]
38. Silva, J.C.; Rodrigues, S.; Feas, X.; Estevinho, L.M. Antimicrobial activity, phenolic profile and role in the inflammation of propolis. Food Chem. Toxicol. 2012, 50, 1790–1795. [CrossRef][PubMed]
39. Xia, D.; Wu, X.; Shi, J.; Yang, Q.; Zhang, Y. Phenolic compounds from the edible seeds extract of Chinese Mei (Prunus mume Sieb. Et Zucc) and their antimicrobial activity. LWT Food Sci. Technol. 2011, 44, 347–349. [CrossRef]
40. Mudnic, I.; Modun, D.; Rastija, V.; Vukovic, J.; Brizic, I.; Katalinic, V.; Kozina, B.; Medic-Saric, M.; Boban, M. Antioxidant and vasodilatory effects of phenolic acids in wine. Food Chem. 2010, 119, 1205–1210. [CrossRef]
41. Santoz, M.D.; Almeida, M.C.; Lopez, N.P.; Souza, G.E.P. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenols CGA. Biol. Pharm. Bull. 2010, 29, 2236–2240. [CrossRef]
42. Selma, M.V.; Espín, J.C.; Tomás-Barberán, F.A. Interaction between phenolics and gut microbiota: Role in human health. J. Agric. Food. Chem. 2009, 57, 6485–6501. [CrossRef][PubMed]
43. Faria, A.; Fernandes, I.; Norberto, S.; Mateus, N.; Calhau, C. Interplay between anthocyanins and gut microbiota. J. Agric. Food Chem. 2014, 62, 6898–6902. [CrossRef][PubMed]
44. Guinane, C.M.; Cotter, P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: Under-standing a hidden metabolic organ. Ther. Adv. Gastroenterol. 2013, 6, 295–308. [CrossRef][PubMed]
45. Cani, P.D.; Delzenne, N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009, 15, 1546–1558. [CrossRef][PubMed]
46. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65. [CrossRef][PubMed]
47. Arboleya, S.; Binetti, A.; Salazar, N.; Fernandez, N.; Solis, G.; Hernandez-Barranco, A.; Margolles, A.; de los Reyes Gavilan, C.G.; Gueimonde, M. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol. Ecol. 2012, 79, 763–772. [CrossRef][PubMed]
48. Tzounis, X.; Rodriguez-Mateos, A.; Vulevic, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am. J. Clin. Nutr. 2011, 93, 62–72. [CrossRef][PubMed]
49. Queipo-Ortuño, M.I.; Boto-Ordóñez, M.; Murri, M.; Gomez-Zumaquero, J.M.; Clemente-Postigo, M.; Estruch, R.; Diaz, F.C.; Andres-Lacueva, C.; Tinahones, F.J. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am. J. Clin. Nutr. 2012, 95, 1323–1334. [CrossRef][PubMed]
50. Rastmanesh, R. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem. Biol. Interact. 2011, 189, 1–8. [CrossRef][PubMed]
51. Hervert-Hernandez, D.; Goñi, I. Dietary polyphenols and human gut microbiota: A review. Food. Rev. Int. 2011, 27, 154–169. [CrossRef]
52. Laparra, J.M.; Sanz, Y. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol. Res. 2010, 61, 219–225. [CrossRef][PubMed]
53. Gotteland, M.; Andrews, M.; Toledo, M.; Muñoz, L.; Caceres, P.; Anziani, A.; Wittig, E.; Speisky, H.; Salazar, G. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 2008, 24, 421–426. [CrossRef][PubMed]
54. Vitali, B.; Ndagijimana, M.; Cruciani, F.; Carnevali, P.; Candela, M.; Guerzoni, M.E.; Brigidi, P. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol. 2010, 10, 4. [CrossRef][PubMed]
55. Hollman, P.C.; Katan, M.B. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem. Toxicol. 1999, 37, 937–942. [CrossRef]
56. Winter, J.; Moore, L.H.; Dowell, V.R.; Bokkenheuser, V.D. C-Ring cleavage of flavonoids by human Intestinal bacteria. Appl. Environ. Microbiol. 1989, 55, 1203–1208. [PubMed]
57. Winter, J.; Popoff, M.R.; Grimont, P.; Bokkenheuser, V.D. Clostridium orbiscindens sp. Nov., a human intestinal bacterium capable of cleaving the flavonoid C-ring. Int. J. Syst. Bacteriol. 1991, 41, 355–357. [CrossRef][PubMed]
58. Rechner, A.R.; Smith, M.A.; Kuhnle, G.; Gibson, G.R.; Debnam, E.S.; Srai, S.K.S.; Moore, K.P.; Rice-Evans, C.A. Colonic metabolism of dietary polyphenol: Influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212–225. [CrossRef][PubMed]
59. Toma’s Barbera’n, F.A.; Clifford, M.N. Flavanones, chalcones and dihydrochalcones nature, occurrence and dietary burden. J. Sci. Food Agric. 2000, 80, 1073–1080. [CrossRef]
60. Robards, K.; Li, X.; Antolovich, M.; Boyd, S. Characterisation of citrus by chromatographic analysis of flavonoids. J. Sci. Food Agric. 1997, 75, 87–101. [CrossRef]
61. Xiao, J.B. Dietary flavonoid aglycones and their glycosides: What show better biological benefits? Crit. Rev. Food Sci. Nutr. 2016. [CrossRef]
62. Xiao, J.B.; Högger, P. Dietary polyphenols and type 2 diabetes: Current insights and future perspectives. Curr. Med. Chem. 2015, 22, 23–38. [CrossRef][PubMed]
63. Xiao, J.B.; Capanoglu, E.; Jassbi, A.R.; Miron, A. Advance on the flavonoid C-glycosides and health benefits. Crit. Rev. Food Sci. Nutr. 2015. [CrossRef][PubMed]
64. Zhang, Y.; Tie, X.W.; Bao, B.L.; Wu, X.Q.; Zhang, Y. Metabolism of flavone C-glucosides and p-coumaric acid from antioxidant of bamboo leaves (AOB) in rats. Br. J. Nutr. 2007, 97, 484–494. [CrossRef][PubMed]
65. Yuan, J.; Wang, J.; Liu, X. Metabolism of dietary soy isoflavones to equol by human intestinal microflora; implications for health. Mol. Nutr. Food Res. 2007, 51, 765–781. [CrossRef][PubMed]
66. Sarkar, F.H.; Li, Y.W. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev. 2002, 21, 265–280. [CrossRef][PubMed]
67. Messina, M. Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy (HRT). Eur. J. Cancer 2000, 36, 71–77. [CrossRef]
68. Cornwell, T.; Cohick, W.; Raskin, I. Dietary phytoestrogens and health. Phytochemistry 2004, 65, 995–1016. [CrossRef][PubMed]
69. Setchell, K.D.R.; Brown, N.M.; Zimmer-Nechemias, L.; Brashear, W.T.; Wolfe, B.; Kirscher, A.S.; Heubi, J.E. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr. 2002, 76, 447–453. [PubMed]
70. Linford, N.J.; Dorsa, D.M. 17b-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 2002, 67, 1029–1040. [CrossRef]
71. Setchell, K.D.R.; Brown, N.M.; Lydeking-Olsen, E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 2002, 32, 3577–3584.
72. Zubik, L.; Meydani, M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr. 2003, 77, 1459–1465. [PubMed]
73. Hur, H.; Rafii, F. Biotransformation of the isoflavonoids biochanin A, formononetin and glycitein by Eubacterium limosum. FEMS Microbiol. Lett. 2000, 192, 21–25. [CrossRef][PubMed]
74. Simons, A.L.; Renouf, M.; Hendrich, S.; Murphy, P.A. Metabolism of glycitein (7;41-dihydroxy- 6-methoxy-isoflavone) by human gut microflora. J. Agric. Food Chem. 2005, 53, 8519–8525. [CrossRef][PubMed]
75. Heinonen, S.; Hoikkala, A.; Wahala, K.; Adlercreutz, H. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J. Steroid Biochem. Mol. Biol. 2003, 87, 285–299. [CrossRef][PubMed]
76. Kuhnle, G.; Spencer, J.P.; Schroeter, H.; Shenoy, B.; Debnam, E.S.; Srai, S.K.; Rice-Evans, C.; Hahn, U. Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun. 2000, 277, 507–512. [CrossRef][PubMed]
77. Vaidyanathan, J.B.; Walle, T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab. Dispos. 2002, 30, 897–890. [CrossRef][PubMed]
78. Hackman, R.M.; Polagruto, J.A.; Zhu, Q.Y.; Sun, B.; Fujii, H.; Keen, C.L. Flavanols: Digestion, absorption and bioactivity. Phytochem. Rev. 2008, 7, 195–208. [CrossRef]
79. Garcıá-Ramirez, B.; Fernández-Larrea, J.; Salvado, M.J.; Ardevol, A.; Arola, L.; Blade, C. Tetramethylated dimeric procyanidins are detected in rat plasma and liver early after oral administration of synthetic oligomeric procyanidins. J. Agric. Food Chem. 2006, 54, 2543–2551. [CrossRef][PubMed]
80. Deprez, S.; Brezillon, C.; Rabot, S.; Philippe, C.; Mila, I.; Lapierre, C.; Scalbert, A. Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 2000, 130, 2733–2738. [PubMed]
81. Rios, L.Y.; Gonthier, M.P.; Remesy, C.; Mila, I.; Lapierre, C.; Lazarus, S.A.; Williamson, G.; Scalbert, A. Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr. 2003, 77, 912–918. [PubMed]
82. Meselhy, M.R.; Nakamura, N.; Hattori, M. Biotransformation of (-)-epicatechin-3-O-gallate by human intestinal bacteria. Chem. Pharm. Bull. 1997, 45, 888–893. [CrossRef][PubMed]
83. Sang, S.; Lambert, J.D.; Ho, C.T.; Yang, C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res. 2011, 64, 87–99. [CrossRef][PubMed]
84. Takagaki, A.; Nanjo, F. Catabolism of (+)-catechin and (-)-epicatechin by rat intestinal microbiota. J. Agric. Food Chem. 2013, 61, 4927–4935. [CrossRef][PubMed]
85. Wang, L.Q.; Meselhy, M.R.; Li, Y.; Nakamura, N.; Min, B.S.; Qin, G.W.; Hattori, M. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem. Pharma. Bull. 2001, 49, 1640–1643. [CrossRef]
86. Kutschera, M.; Engst, W.; Blaut, M.; Braune, A. Isolation of catechin-converting human intestinal bacteria. J. Appl. Microbiol. 2011, 111, 165–175. [CrossRef][PubMed]
87. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, M.E.; Edwards, C.A.; Crozier, A. Green tea flavan-3-ols: Colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food. Chem. 2010, 58, 1296–1304. [CrossRef][PubMed]
88. Schantz, M.; Erk, T.; Richling, E. Metabolism of green tea catechins by the human small intestine. Biotechnol. J. 2010, 5, 1050–1059. [CrossRef][PubMed]
89. Van’t Slot, G.; Humpf, H.U. Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model. J. Agric. Food. Chem. 2009, 57, 8041–8048. [CrossRef][PubMed]
90. Meng, X.; Sang, S.; Zhu, N.; Lu, H.; Sheng, S.; Lee, M.J.; Ho, C.T.; Yang, C.S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol. 2002, 15, 1042–1050. [CrossRef][PubMed]
91. Takagaki, A.; Nanjo, F. Metabolism of (-)-epigallocatechin gallate by rat intestinal flora. J. Agric. Food Chem. 2010, 58, 1313–1321. [CrossRef][PubMed]
92. Kohri, T.; Matsumoto, N.; Yamakawa, M.; Suzuki, M.; Nanjo, F.; Hara, Y.; Oku, N. Metabolic fate of (-)-[4-(3)H]epigallocatechin gallate in rats after oral administration. J. Agric. Food. Chem. 2001, 49, 4102–4112. [CrossRef]
93. Kohri, T.; Nanjo, F.; Suzuki, M.; Seto, R.; Matsumoto, N.; Yamakawa, M.; Hojo, H.; Hara, Y.; Desai, D.; Amin, S. et al. Synthesis of (-)-[4–3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J. Agric. Food. Chem. 2001, 49, 1042–1048. [CrossRef][PubMed]
94. Fleschhut, J.; Kratzer, F.; Rechkemmer, G.; Kulling, S.E. Stability and biotransformation of various dietary anthocyanins in vitro. Eur. J. Nutr. 2006, 45, 7–18. [CrossRef][PubMed]
95. Keppler, K.; Humpf, H.U. Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg. Med. Chem. 2005, 13, 5195–5205. [CrossRef][PubMed]
96. Wang, H.; Nair, M.G.; Strasburg, G.M.; Chang, Y.C.; Booren, A.M.; Gray, J.I.; DeWitt, D.L. Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J. Nat. Prod. 1999, 62, 294–296. [CrossRef][PubMed]
97. Hou, D.X. Potential mechanisms of cancer chemoprevention by anthocyanins. Curr. Mol. Med. 2003, 3, 149–159. [CrossRef][PubMed]
98. Katsube, N.; Iwashita, K.; Tsushida, T.; Yamaki, K.; Kobori, M. Induction of apoptosis in cancer cells by Bilberry (Vaccinium. myrtillus) and the anthocyanins. J. Agric. Food Chem. 2003, 51, 68–75. [CrossRef][PubMed]
99. Xiao, J.B.; Högger, P. Advance in pharmacokinetics of bioactive polyphenols. Curr. Drug Metab. 2014, 15, 1–2. [CrossRef][PubMed]
100. Matsumoto, H.; Inaba, H.; Kishi, M.; Tominaga, S.; Hirayama, M.; Tsuda, T. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem. 2001, 49, 1546–1551. [CrossRef][PubMed]
101. Vitaglione, P.; Donnarumma, G.; Napolitano, A.; Galvano, F.; Gallo, A.; Scalfi, L.; Fogliano, V. Protocatechuic acid is the major human metabolite of cyanidin-glucosides. J. Nutr. 2007, 137, 2043–2048. [PubMed]
102. Kahle, K.; Kraus, M.; Scheppach, W.; Ackermann, M.; Ridder, F.; Richling, E. Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon after ingestion? Mol. Nutr. Food Res. 2006, 50, 418–423. [CrossRef][PubMed]
103. Aura, A.M.; Martin-Lopez, P.; O’Leary, K.A.; Williamson, G.; Oksman-Caldentey, K.M.; Poutanen, K.; Santos-Buelga, C. In vitro metabolism of anthocyanins by human gut microflora. Eur. J. Nutr. 2005, 44, 133–142. [CrossRef][PubMed]
104. El Mohsen, M.A.; Marks, J.; Kuhnle, G.; Moore, K.; Debnam, E.; Srai, S.K.; Rice-Evans, C.; Spencer, J.P. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br. J. Nutr. 2006, 95, 51–58. [CrossRef][PubMed]
105. Hassimotto, N.M.A.; Genovese, M.I.; Lajolo, F.M. Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats. Nutr. Res. 2008, 28, 198–207. [CrossRef][PubMed]
106. Hanske, L.; Engst, W.; Loh, G.; Sczesny, S.; Blaut, M.; Braune, A. Contribution of gut bacteria to the metabolism of cyanidin 3-glucoside in human microbiota-associated rats. Br. J. Nutr. 2013, 109, 1433–1441. [CrossRef][PubMed]
107. Wu, X.; Pittman Lii, H.E.; Hager, T.; Hager, A.; Howard, L.; Prior, R.L. Phenolic acids in black raspberry and in the gastrointestinal tract of pigs following ingestion of black raspberry. Mol. Nutr. Food Res. 2009, 53, 76–84. [CrossRef][PubMed]
108. Tsuda, T.; Horio, F.; Osawa, T. Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett. 1999, 449, 179–182. [CrossRef]
109. Han, S.J.; Ryu, S.N.; Trinh, H.T.; Joh, E.H.; Jang, S.Y.; Han, M.J.; Kim, D.H. Metabolism of cyanidin-3-O-beta-D-glucoside isolated from black colored rice and its antiscratching behavioral effect in mice. J. Food Sci. 2009, 74, 253–258. [CrossRef][PubMed]
110. Williamson, G.; Clifford, M.N. Colonic metabolites of berry polyphenols: The missing link to biological activity? Br. J. Nutr. 2010, 104, 48–66. [CrossRef][PubMed]
111. Andreasen, M.F.; Kroon, P.A.; Williamson, G.; Garcia-Conesa, M.-T. Intestinal release and uptake of phenolic antioxidant diferulic acids. Free Radic. Biol. Med. 2001, 31, 304–314. [CrossRef]
112. Rondini, L.; Peyrat-Maillard, M.-N.; Marsset-Baglieri, A.; Fromentin, G.; Durand, P.; Tome, P.; Prost, M.; Berset, C. Bound ferulic acid from bran is more bioavailable than the free compound in rat. J. Agric. Food Chem. 2004, 52, 4338–4343. [CrossRef][PubMed]
113. Andreasen, M.F.; Kroon, P.A.; Williamson, G.; Garcia Conesa, M.T. Esterase activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals. J. Agric. Food Chem. 2001, 49, 5679–5684. [CrossRef][PubMed]
114. Gonthier, M.P.; Remesy, C.; Scalbert, A.; Cheynier, V.; Souquet, J.M.; Poutanen, K.; Aura, A.M. Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomed. Pharmacotherapy 2006, 60, 536–540. [CrossRef][PubMed]
115. Peppercorn, M.A.; Goldman, P. Caffeic acid metabolism by bacteria of the human gastrointestinal tract. J. Bacteriol. 1971, 108, 996–1000. [PubMed]
116. Andreasen, M.F.; Christensen, L.P.; Meyer, A.S.; Hansen, A. Content of phenolic acids and ferulic acid dehydrodimers in 17 Rye (Secale cereale L.) varieties. J. Agric. Food Chem. 2000, 48, 2837–2842. [CrossRef][PubMed]
117. Braune, A.; Bunzel, M.; Yonekura, R.; Blaut, M. Conversion of dehydrodiferulic acids by human intestinal microbiota. J. Agric. Food Chem. 2009, 57, 3356–3362. [CrossRef][PubMed]
118. Xie, L.Y.; Bolling, B.W. Characterisation of stilbenes in California almonds (Prunus dulcis) by UHPLC-MS. Food Chem. 2015, 148, 300–306. [CrossRef][PubMed]
119. Mulat, D.G.; Latva-Maenpaa, H.; Koskela, H.; Saranpaa, P.; Wahala, K. Rapid chemical characterisation of stilbenes in the root bark of Norway spruce by off-line HPLC/DAD-NMR. Phytochem. Anal. 2014, 25, 529–536. [CrossRef][PubMed]
120. Folmer, F.; Basavaraju, U.; Jaspars, M.; Hold, G.; El-Omar, E.; Dicato, M.; Diederich, M. Anticancer effects of bioactive berry compounds. Phytochem. Rev. 2014, 13, 295–322. [CrossRef]
121. Fu, Y.J.; Kadioglu, O.; Wiench, B.; Wei, Z.F.; Gao, C.; Luo, M.; Gu, C.B.; Zu, Y.G.; Efferth, T. Cell cycle arrest and induction of apoptosis by cajanin stilbene acid from Cajanus cajun in breast cancer cells. Phytomedicine 2015, 22, 462–468. [CrossRef][PubMed]
122. Liu, P.; Wang, Y.R.; Gao, J.Y.; Lu, Z.Y.; Yin, W.P.; Deng, R.X. Resveratrol trimers from seed cake of Paeonia rockii. Molecules 2014, 19, 19549–19556. [CrossRef][PubMed]
123. Bode, L.M.; Bunzel, D.; Huch, M.; Cho, G.S.; Ruhland, D.; Bunzel, M.; Bub, A.; Franz, C.M.A.P.; Kulling, S.E. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am. J. Clin. Nutr. 2013, 97, 295–309. [CrossRef][PubMed]
124. Wang, D.G.; Zhang, Z.W.; Ju, J.F.; Wang, X.Y.; Qiu, W.J. Investigation of piceid metabolites in rat by liquid chromatography tandem mass spectrometry. J. Chromatogr. B 2011, 879, 69–74. [CrossRef][PubMed]
125. Cassidy, A.; Hanley, B.; Lamuela-Raventos, R.M. Isoflavones: Lignans and stilbenes; origins, metabolism and potential importance to human health. J. Sci. Food Agric. 2000, 80, 1044–1062. [CrossRef]
126. Touillaud, M.S.; Thiebaut, A.C.M.; Fournier, A.; Niravong, M.; Boutron-Ruault, M.C.; Clavel-Chapelon, F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J. Natl. Cancer Inst. 2007, 99, 475–486. [CrossRef][PubMed]
127. Aura, A.-M.; Oikarinen, S.; Mutanen, M.; Heinonen, S.-M.; Ad-lercreutz, H.C.T.; Virtanen, H.; Poutanen, K.S. Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model. Eur. J. Nutr. 2006, 45, 45–51. [CrossRef][PubMed]
128. Possemiers, S.; Bolca, S.; Eeckhaut, E.; Depypere, H.; Verstraete, W. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: Producer phenotyping and relation with intestinal community. FEMS Microbiol. Ecol. 2007, 6, 1372–1383. [CrossRef][PubMed]
129. Rowland, I.; Faughnan, M.; Hoey, L.; Wahala, K.; Williamson, G.; Cassidy, A. Bioavailability of phytoestrogens. Br. J. Nutr. 2003, 89, 45–58.
130. Bowey, E.; Adlercreutz, H.; Rowland, I. Metabolism of isoflavones and lignans by the gut microflora: A study in germ-free and human flora associated rats. Food Chem. Toxicol. 2003, 41, 631–636. [CrossRef]
131. Eeckhaut, E.; Struijs, K.; Possemiers, S.; Vincken, J.P.; Keukeleire, D.D.; Verstraete, W. Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. J. Agric. Food Chem. 2008, 56, 4806–4812. [CrossRef][PubMed]
132. Wang, L.Q.; Meselhy, M.R.; Li, Y.; Qin, G.W.; Hattori, M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem. Pharm. Bull. 2000, 48, 1606–1610. [CrossRef][PubMed]
133. Blaut, M.; Clavel, T. Metabolic diversity of the intestinal microbiota: Implications for health and disease. J. Nutr. 2007, 137, 751–755.
134. Bohn, T. Bioavailability of non-provitamin a carotenoids. Curr. Nutr. Food Sci. 2008, 4, 240–258. [CrossRef]
135. Bouayed, J.; Hoffmann, L.; Bohn, T. Total phenolics, flavonoids, anthocyanins and antioxidant activity following simulated gastro-intestinal digestion and dialysis of apple varieties: Bioaccessibility and potential uptake. Food Chem. 2011, 128, 14–21. [CrossRef][PubMed]
136. Kemperman, R.A.; Bolca, S.; Roger, L.C.; Vaughan, E.E. Novel approaches for analysing gut microbes and dietary polyphenols: Challenges and opportunities. Microbiology 2010, 156, 3224–3231. [CrossRef][PubMed]
137. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81, 243–255.
138. Hollman, P.C.; Katan, M.B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 1997, 51, 305–310. [CrossRef]
139. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747. [PubMed]
140. Lampe, J.W. Interindividual differences in response to plant-based diets: Implications for cancer risk. Am. J. Clin. Nutr. 2009, 89, 1553–1557. [CrossRef][PubMed]
141. Padayachee, A.; Netzel, G.; Netzel, M.; Day, L.; Zabaras, D.; Mikkelsen, D.; Gidley, M.J. Binding of polyphenols to plant cell wall analogues—Part 2: Phenolic acids. Food Chem. 2012, 135, 2287–2292. [CrossRef][PubMed]
142. Gil-Izquierdo, A.; Gil, M.I.; Ferreres, F.; Tomas-Barberan, F.A. In vitro availability of flavonoids and other phenolics in orange juice. J. Agric. Food Chem. 2001, 49, 1035–1041. [CrossRef][PubMed]
143. Mandalaria, G.; Tomaino, A.; Rich, G.T.; Lo Curto, R.; Arcoraci, T.; Martorana, M.; Bisignano, C.; Saija, A.; Parker, M.L.; Waldron, K.W. et al. Polyphenol and nutrient release from skin of almonds during simulated human digestion. Food Chem. 2010, 122, 1083–1088. [CrossRef]
144. Ozdal, T.; Capanoglu, E.; Altay, F. A review on protein–phenolic interactions and associated changes. Food Res. Int. 2013, 51, 954–970. [CrossRef]
145. Saura Calixto, F. Dietary fiber as a carrier of dietary antioxidants: An essential physiological function. J. Agric. Food Chem. 2011, 59, 43–49. [CrossRef][PubMed]
146. Ortega, N.; Reguant, J.; Romero, M.P.; Macia, A.; Motilva, M.J. Effect of fat content on the digestibility and bioaccessibility of cocoa polyphenol by an in vitro digestion model. J. Agric. Food Chem. 2009, 57, 5743–5749. [CrossRef][PubMed]
147. Tremaroli, V.; Bäckhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489, 242–249. [CrossRef][PubMed]
148. Rothwell, J.A.; Urpi-Sarda, M.; Boto-Ordonez, M.; Knox, C.; Llorach, R.; Eisner, R.; Cruz, J.; Neveu, V.; Wishart, D.; Manach, C. et al. Phenol-Explorer 2.0: A major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database 2012, 2012. [CrossRef][PubMed]
149. Xu, J.; Bjursell, M.K.; Himrod, J.; Deng, S.; Carmichael, L.K.; Chiang, H.C.; Hooper, L.V.; Gordon, J.I. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299, 2074–2076. [CrossRef][PubMed]
150. Martens, E.C.; Lowe, E.C.; Chiang, H.; Pudlo, N.A.; Wu, M.; McNulty, N.P.; Abbott, D.W.; Henrissat, B.; Gilbert, H.J.; Bolam, D.N. et al. Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol. 2011, 9, 2492. [CrossRef][PubMed]
151. Donohoe, D.R.; Garge, N.; Zhang, X.; Sun, W.; O’Connell, T.M.; Bunger, M.K.; Bultman, S.J. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011, 13, 517–526. [CrossRef][PubMed]
152. Bäckhed, F.; Manchester, J.K.; Semenkovich, C.F.; Gordon, J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA 2007, 104, 979–984. [CrossRef][PubMed]
153. Esposito, D.; Damsud, T.; Wilson, M.; Grace, M.H.; Strauch, R.; Li, X.; Lila, M.A.; Komarnytsky, S. Black currant anthocyanins attenuate weight gain and improve glucose metabolism in diet-induced obese mice with intact, but not disrupted, gut microbiome. J. Agric. Food Chem. 2015, 63, 6172–6180. [CrossRef][PubMed]
154. Ludwig, I.A.; Mena, P.; Calani, L.; Borges, G.; Pereira-Caro, G.; Bresciani, L.; del Rio, D.; Lean, M.E.J.; Crozier, A. New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. Free Radic. Biol. Med. 2015, 89, 758–769. [CrossRef][PubMed]
155. Cerdá, B.; Tomás-Barbéran, F.A.; Espín, J.C. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: Identification of biomarkers and individual variability. J. Agric. Food Chem. 2005, 53, 227–235. [CrossRef][PubMed]
156. Seeram, N.P.; Henning, S.M.; Zhang, Y.; Suchard, M.; Li, Z.; Heber, D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 h. J. Nutr. 2006, 136, 2481–2485. [PubMed]
157. González-Barrio, R.; Borges, G.; Mullen, W.; Crozier, A. Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J. Agric. Food. Chem. 2010, 58, 3933–3939. [CrossRef][PubMed]
158. González-Barrio, R.; Edwards, C.A.; Crozier, A. Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: In vivo and in vitro studies. Drug Metab. Dispos. 2011, 39, 1680–1688. [CrossRef][PubMed]
159. Dudonné, S.; Varin, T.V.; Anhê, F.F.; Dubé, P.; Roy, D.; Pilon, G.; Marette, A.; Levy, E.; Jacquot, C.; Urdaci, M. et al. Modulatory effects of a cranberry extract co-supplementation with Bacillus subtilis CU1 probiotic on phenolic compounds bioavailability and gut microbiota composition in high-fat diet-fed mice. PharmaNutrition 2015, 3, 89–100. [CrossRef]
160. Halliwell, B.; Rafter, J.; Jenner, A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: Direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 2005, 81, 268–276.
161. Choy, Y.Y.; Jaggers, G.K.; Oteiza, P.I.; Waterhouse, A.L. Bioavailability of intact proanthocyanidins in the rat colon after ingestion of grape seed extract. J. Agric. Food Chem. 2013, 61, 121–127. [CrossRef][PubMed]
162. He, J.; Magnuson, B.A.; Giusti, M.M. Analysis of anthocyanins in rat intestinal contentsimpact of anthocyanin chemical structure on fecal excretion. J. Agric. Food Chem. 2005, 53, 2859–2866. [CrossRef][PubMed]
163. Gibson, G.R. Prebiotics as gut microflora management tools. J. Clin. Gastroenterol. 2008, 42, 75–79. [CrossRef][PubMed]
164. Burcelin, R.; Garidou, L.; Pomie, C. Immuno-microbiota cross and talk: The new paradigm of metabolic diseases. Semin. Immunol. 2012, 24, 67–74. [CrossRef][PubMed]
165. Rastall, R.A.; Gibson, G.R.; Gill, H.S.; Guarner, F.; Klaenhammer, T.R.; Pot, B.; Reid, G.; Rowland, I.R.; Sanders, M.E. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: An overview of enabling science and potential applications. FEMS Microbiol. Ecol. 2005, 52, 145–152. [CrossRef][PubMed]
166. Duda-Chodak, A. The inhibitory effect of polyphenols on human gut microbiota. J. Physiol. Pharmacol. 2012, 63, 497–503. [PubMed]
167. Etxeberria, U.; Arias, N.; Boqué, N.; Macarulla, M.T.; Portillo, M.P.; Martínez, J.A.; Milagro, F.I. Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. J. Nutr. Biochem. 2015, 26, 651–660. [CrossRef][PubMed]
168. Kawabata, K.; Sugiyama, Y.; Sakano, T.; Ohigashi, H. Flavonols enhanced production of anti-inflammatory substance(s) by Bifidobacterium adolescentis: Prebiotic actions of galangin, quercetin, and fisetin. Biofactors 2013, 39, 422–429. [CrossRef][PubMed]
169. Parkar, S.G.; Stevenson, D.E.; Skinner, M.A. The potential influence of fruit polyphenols on colonic microflora and human gut health. Int. J. Food Microbiol. 2008, 124, 295–298. [CrossRef][PubMed]
170. Clavel, T.; Fallani, M.; Lepage, P.; Levenez, F.; Mathey, J.; Rochet, V.; Serezat, M.; Sutren, M.; Henderson, G.; Bennetau Pelissero, C. et al. Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J. Nutr. 2005, 135, 2786–2792. [PubMed]
171. Tzounis, X.; Vulevic, J.; Kuhnle, G.G.C.; George, T.; Leonczak, J.; Gibson, G.R.; Kwik-Uribe, C.; Spencer, J.P.M. Flavanol monomer-induced changes to the human faecal microflora. Br. J. Nutr. 2008, 99, 782–792. [CrossRef][PubMed]
172. Cueva, C.; Sánchez-Patán, F.; Monagas, M.; Walton, G.E.; Gibson, G.R.; Martín-Álvarez, P.J.; Bartolome, B.; Moreno-Arribas, M.V. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: Changes in microbial groups and phenolic metabolites. FEMS Microbiol. Ecol. 2013, 83, 792–805. [CrossRef][PubMed]
173. Choy, Y.Y.; Quifer-Rada, P.; Holstege, D.M.; Frese, S.A.; Calvert, C.C.; Mills, D.A.; Lamuela-Raventos, R.M.; Waterhouse, A.L. Phenolic metabolites and substantial microbiome changes in pig feces by ingesting grape seed proanthocyanidins. Food. Funct. 2014, 5, 2298–2308. [CrossRef][PubMed]
174. Hidalgo, M.; Oruna-Concha, M.J.; Kolida, S.; Walton, G.E.; Kallithraka, S.; Spencer, J.P.; de Pascual-Teresa, S. Metabolism of anthocyanins by human gut microflora and their influence on gut bacterial growth. J. Agric. Food Chem. 2012, 60, 3882–3890. [CrossRef][PubMed]
175. Bialonska, D.; Kasimsetty, S.G.; Schrader, K.K.; Ferreira, D. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria. J. Agric. Food Chem. 2009, 57, 8344–8349. [CrossRef][PubMed]
176. Bialonska, D.; Ramnani, P.; Kasimsetty, S.G.; Muntha, K.R.; Gibson, G.R.; Ferreira, D. The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int. J. Food Microbiol. 2010, 140, 175–182. [CrossRef][PubMed]
177. Larrosa, M.; Gonzalez-Sarrıas, A.; Yanez-Gascon, M.J.; Selma, M.V.; Azorın-Ortuno, M.; Toti, S.; Tomas-Barberan, F.A.; Dolara, P.; Espın, J.C. Anti-inflammatory properties of a pome-granate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on the phenolic metabolism. J. Nutr. Biochem. 2010, 21, 717–725. [CrossRef][PubMed]
178. Li, Z.; Henning, S.M.; Lee, R.-P.; Lu, Q.-Y.; Summanen, P.H.; Thames, G.; Corbett, K.; Downes, J.; Tsena, C.-H.; Finegold, S.M. et al. Pomegranate extract induces metabolite formation and changes stool microbiota in healthy volunteers. Food Funct. 2015, 6, 2487–2495. [CrossRef][PubMed]
179. Larrosa, M.; Yanez-Gascon, M.J.; Selma, M.V.; Gonzalez-Sarrıas, A.; Toti, S.; Ceron, J.J.; Tomas-Barberan, F.A.; Dolara, P.; Espın, J.C. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSS-induced colitis rat model. J. Agric. Food Chem. 2009, 57, 2211–2220. [CrossRef][PubMed]
180. Qiao, Y.; Sun, J.; Xia, S.; Tang, X.; Shi, Y.; Le, G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 2014, 5, 1241–1249. [CrossRef][PubMed]
181. Niemi, P.; Aura, A.M.; Maukonen, J.; Smeds, A.I.; Mattila, I.; Niemelä, K.; Tamminen, T.; Fauulds, C.B.; Buchert, J.; Poutanen, K. Interactions of a lignin-rich fraction from Brewer’s spent grain with gut microbiota in vitro. J. Agric. Food Chem. 2013, 61, 6754–6762. [CrossRef][PubMed]